Caring for the breast cancer survivor’s health and well-being

Figure 1 Recommended management strategy for patients with diagnosed nonmetastatic breast cancer[97]. This management strategy is largely based on influence from results in non-breast cancer populations. BMD: Bone mass density; DEXA: Dual energy X-ray absorptiometry bone scan. Reprinted with permission. © (2003) American Society of Clinical Oncology. All rights reserved.

Figure 2 Adjuvant treatment associated with ovarian suppression/failure with or without concomitant aromatase inhibitor use in women who experience premature menopause[92]. ^aErythrocyte sedimentation rate, full blood count, bone and liver function (calcium phosphate, alkaline phosphatase, albumin, AST/γGT), serum creatinine, endomysial antibodies, serum thyroid stimulating hormone; ^bAlendronate 70 mg per week, risedronate 35 mg per week, ibandronate (150 mg po monthly or 3 mg iv 3-monthly), zoledronic acid 4 mg iv 6-monthly; ^cTo be given as ≥ 1 g of calcium + ≥ 800 IU of vitamin D; ^dBiochemical markers such as serum C-terminal telopeptide of type I collagen or urinary N-telopeptide of type I collagen. Reprinted with permission. © (2008) Elsevier.

Figure 3 Postmenopausal adjuvant treatment with aromatase inhibitors[92]. ^aPrevious low-trauma fracture after age 50, parental history of hip fracture, alcohol intake of ≥ 4 units/day, diseases associated with secondary osteoporosis, prior corticosteroids for > 6 mo, low BMI (< 22); ^bErythrocyte sedimentation rate, full blood count, bone and liver function (calcium phosphate, alkaline phosphatase, albumin, AST/γGT), serum creatinine, endomysial antibodies, serum thyroid stimulating hormone; ^cAlendronate 70 mg per week, risedronate 35 mg per week, ibandronate (150 mg po monthly or 3 mg iv 3-monthly), zoledronic acid 4 mg iv 6-monthly; ^dTo be given as ≥ 1 g of calcium + ≥ 800 IU of vitamin D; ^eBiochemical markers such as serum C-terminal telopeptide of type I collagen or urinary N-telopeptide of type I collagen. Reprinted with permission. © (2008) Elsevier.